Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Pre-Approval Of Commercial Speech: “Coming Soon” To DTC Device Ads?

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed is urging FDA to consider a pre-approval policy for direct-to-consumer advertising within the Center for Devices & Radiological Health

You may also be interested in...



CDRH More Reliant On SEC, FTC For Ad/Promotion Vigilance Under Policy Shift

The Center for Devices & Radiological Health increasingly is looking to other federal agencies to help regulate medical device advertising and promotion as it scales back its own claim enforcement activities

CDRH More Reliant On SEC, FTC For Ad/Promotion Vigilance Under Policy Shift

The Center for Devices & Radiological Health increasingly is looking to other federal agencies to help regulate medical device advertising and promotion as it scales back its own claim enforcement activities

McClellan Reinforces FDA Advertising Surveillance, Warning Letter Policy

FDA remains committed to its vigilant oversight of direct-to-consumer advertising following a request for expedited handling of DTC ad warning letters by the General Accounting Office

Related Content

UsernamePublicRestriction

Register

MT017179

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel